These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 9607389)

  • 61. Different effects of fosinopril and atenolol on wave reflections in hypertensive patients.
    Chen CH; Ting CT; Lin SJ; Hsu TL; Yin FC; Siu CO; Chou P; Wang SP; Chang MS
    Hypertension; 1995 May; 25(5):1034-41. PubMed ID: 7737712
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effects of fosinopril treatment on blood pressure during physical and mental stress test in essential hypertension.
    Yesilbursa D; Serdar A; Ilcol B; Türel B; Cordan J
    Blood Press; 1999; 8(5-6):269-72. PubMed ID: 10803486
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Cerebrovascular support for cognitive processing in hypertensive patients is altered by blood pressure treatment.
    Jennings JR; Muldoon MF; Price J; Christie IC; Meltzer CC
    Hypertension; 2008 Jul; 52(1):65-71. PubMed ID: 18519845
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Fosinopril: a new generation of angiotensin-converting enzyme inhibitors.
    Weber MA
    J Cardiovasc Pharmacol; 1992; 20 Suppl 10():S7-12. PubMed ID: 1283429
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Arterial pressure lowering effect of chronic atenolol therapy in hypertension and vasoconstrictor sympathetic drive.
    Burns J; Mary DA; Mackintosh AF; Ball SG; Greenwood JP
    Hypertension; 2004 Oct; 44(4):454-8. PubMed ID: 15326085
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Recent outcome trials of newer antihypertensives.
    Bakir S; Oparil S
    Curr Hypertens Rep; 1999 Jun; 1(3):238-40. PubMed ID: 10981072
    [No Abstract]   [Full Text] [Related]  

  • 67. Fosinopril: an overview.
    Guthrie R
    Am J Cardiol; 1993 Dec; 72(20):22H-24H. PubMed ID: 8285178
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Evolution of the bone mass of hypertense menopausal women in treatment with fosinopril].
    García-Testal A; Monzó A; Rabanaque G; González A; Romeu A
    Med Clin (Barc); 2006 Nov; 127(18):692-4. PubMed ID: 17169295
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Pharmacokinetic and pharmacodynamic features of hypertensive drugs in treatment of patients with arterial hypertension associated with liver disease].
    Mikheeva OM
    Eksp Klin Gastroenterol; 2010; (6):95-101. PubMed ID: 20731173
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Pharmacometabolomics reveals racial differences in response to atenolol treatment.
    Wikoff WR; Frye RF; Zhu H; Gong Y; Boyle S; Churchill E; Cooper-Dehoff RM; Beitelshees AL; Chapman AB; Fiehn O; Johnson JA; Kaddurah-Daouk R;
    PLoS One; 2013; 8(3):e57639. PubMed ID: 23536766
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Hypertension combined with atherosclerotic lesions in carotid arteries: should angiotensin converting enzyme inhibitors be prescribed?].
    Fomin VV; Moiseev SV
    Kardiologiia; 2005; 45(12):99-102. PubMed ID: 16353055
    [No Abstract]   [Full Text] [Related]  

  • 72. Insulin receptor number in arterial hypertension: response to treatment with fosinopril or atenolol.
    Makris T; Krespi P; Triposkiadis F; Votteas V; Hatzizaharias A; Kyriakidis M
    Am J Hypertens; 1998 Apr; 11(4 Pt 1):494-6. PubMed ID: 9607389
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Skeletal muscle angiotensin-converting enzyme and its relationship to blood pressure in primary hypertension and healthy elderly men.
    Reneland R; Haenni A; Andersson PE; Andrén B; Lithell H
    Blood Press; 1999; 8(1):16-22. PubMed ID: 10412878
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Metabolic effects of long-term angiotensin-converting enzyme inhibition with fosinopril in patients with essential hypertension: relationship to angiotensin-converting enzyme inhibition.
    Reneland R; Andersson PE; Haenni A; Lithell H
    Eur J Clin Pharmacol; 1994; 46(5):431-6. PubMed ID: 7957538
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study.
    Mallion JM; Chamontin B; Asmar R; De Leeuw PW; O'Brien E; Duprez D; O'Rourke MF; Rahn KH; Romero R; Battegay E; Hitzenberger G; Safar ME;
    Am J Hypertens; 2004 Mar; 17(3):245-51. PubMed ID: 15001199
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Metabolic effects of spirapril and atenolol: results from a randomized, long-term study.
    Hakamäki T; Lehtonen A
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):227-30. PubMed ID: 9208336
    [TBL] [Abstract][Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.